间歇性跛行患者6分钟步行试验的重测信度、一致性与最小可检测变化
该研究在瑞典Sahlgrenska大学医院血管外科门诊招募102例稳定间歇性跛行患者,间隔至少30分钟重复进行6分钟步行试验,评估重测信度、一致性、测量标准误和最小可检测变化。结果显示组内相关系数0.95(95%CI 0.9-0.97),测量标准误16.6米(95%CI 14.6-19.3),最小可检测变化46米,提示单次测试即可,干预后变化需超过46米才具统计学意义。
要点
- 6分钟步行试验在间歇性跛行患者中重测信度优秀,ICC为0.95。
- 测量标准误为16.6米,最小可检测变化为46米。
- 干预后步行距离改善或恶化需超过46米才可认为变化显著。
核心结论
- 6分钟步行试验在间歇性跛行患者中具有优秀的重测信度,单次测试即可满足评估需求。
- 个体干预后最大步行距离变化需超过46米才能在95%置信水平下认为显著。
研究设计与样本
- 信度与一致性研究,从瑞典Sahlgrenska大学医院血管外科门诊招募102例稳定间歇性跛行患者(平均年龄72±7.4岁,43例女性)。
- 患者间隔至少30分钟重复进行两次6分钟步行试验。
主要发现
- 两次测试平均步行距离均为397.8米(标准差81.2米,N=100),个体步行距离范围175至600米。
- 组内相关系数0.95(95%CI 0.9-0.97),测量标准误16.6米(95%CI 14.6-19.3),测量标准误百分比4.2%,最小可检测变化46米。
- 5例观测值(5%)位于一致性界限外,存在小的比例偏倚,差值散点随均值增大而减小。
关键数值与推荐
- 重测信度:组内相关系数0.95(95%CI 0.9-0.97)。
- 测量标准误:16.6米(95%CI 14.6-19.3),百分比4.2%。
- 最小可检测变化:46米。
临床怎么用
- 间歇性跛行患者每次测试场合仅需进行一次6分钟步行试验。
- 干预后最大步行距离变化超过46米才可认为具有95%置信度的显著变化。
- 6分钟步行试验简单且临床实用,可广泛用于评估不同干预措施的效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Standardized walk tests are important for objective assessment of walking distance in patients with intermittent claudication (IC). The 6-minute walk test (6MWT) has been suggested to correlate more closely than testing on a treadmill with everyday ambulatory function, but its measurement properties have hardly been studied in IC. The aim of this study was to determine the test-retest reliability, agreement, standard error of measurement (SEM), and minimal detectable change of the 6MWT in patients with IC. METHODS: This reliability and agreement study recruited 102 patients with stable IC (mean age, 72 ± 7.4 years; 43 women) from the vascular surgery outpatient clinic at Sahlgrenska University Hospital in Sweden. The patients performed the 6MWT twice, with at least 30 minutes of rest between tests. To determine test-retest reliability, the intraclass correlation coefficient was calculated. Bland-Altman plots were used to measure agreement. RESULTS: The mean walking distance in both test and retest was 397.8 m (standard deviation, 81.2 m; N = 100), and the individual walking distance varied from 175 to 600 m. Excellent test-retest reliability for the 6MWT (intraclass correlation coefficient, 0.95; 95% confidence interval, 0.9-0.97) was observed. The SEM was 16.6 m (95% confidence interval, 14.6-19.3), the SEM percentage was 4.2%, and the minimal detectable change was 46 m. Five observations (5%) were positioned outside the limits of agreement; there was a small proportional bias, and the scatter of values for differences decreased as the average values increased. CONCLUSIONS: The excellent test-retest reliability implies that it is sufficient for a patient with IC to perform the 6MWT once, at every test occasion. For the individual, an improvement or deterioration in maximum walking distance of >46 m after an intervention would be required to be 95% confident that the change is significant. Being a simple and clinically useful test, the 6MWT can be widely used to evaluate the effects of different interventions in patients with IC.
引用
- Sandberg A, Cider Å, Jivegård L, et al. Test-retest reliability, agreement, and minimal detectable change in the 6-minute walk test in patients with intermittent claudication. J Vasc Surg. 2019. PMID: 31147129. doi:10.1016/j.jvs.2019.02.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。